The medication vibegron led to improvements in symptoms of overactive bladder and overall quality of life in men undergoing treatment for benign prostatic hyperplasia, according to findings from a ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...

Patients with benign prostatic hyperplasia (BPH) with preoperative overactive bladder (OAB) have higher postoperative storage symptoms despite comparable overall symptom improvement, according to a ...

As men get older, it’s common to notice changes when going to the bathroom. If you feel like you can’t fully empty your bladder, you have a weak urine stream, or you’re waking up often at night to use ...

At some point in their lives, nearly all men will experience some degree of prostate enlargement. Benign prostatic hyperplasia (BPH) is a very common condition where the prostate has grown enough to ...

DEAR DR. ROACH: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn’t provide any ...

For many men, changes in urination are often dismissed as an inevitable part of ageing. Frequent nighttime trips to the bathroom, a weak urine stream or difficulty emptying the bladder may seem like ...

Dear Dr. Roach: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn't provide any ...

OAB is commonly treated with a class of medicines called anticholinergics or antimuscarinics. These medicines block chemicals in your body that help the bladder to squeeze. By blocking these chemicals ...

Low-dose pyridostigmine is an effective treatment for men with underactive bladder who undergo TURP for BPH with BOO, trial findings suggest. Administration of pyridostigmine following transurethral ...